CVE-2025-64048: YCCMS 3.4 contains a stored cross-site scripting (XSS) vulnerability in the article management functionality
CVE-2025-64048 is a medium-severity flaw (CVSS 6.1) affecting yccms. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
YCCMS 3.4 contains a stored cross-site scripting (XSS) vulnerability in the article management functionality. The vulnerability exists in the add() and getPost() functions within the ArticleAction.class.php file due to improper neutralization of user input in the article title field.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.2% (top 91%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2025-11-24 |
| Last modified | 2026-07-05 |
Last updated 2026-07-05 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2025-64048?
yccms: downgrade or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2025-64048 being exploited?
CVE-2025-64048 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2025-64048 affect?
CVE-2025-64048 affects yccms. Severity is medium (CVSS 6.1). YCCMS 3.4 contains a stored cross-site scripting (XSS) vulnerability in the article management functionality. The vulnerability exists in the add() and getPost() functions within the ArticleAction.class.php file due to improper neutralizati
How urgent is CVE-2025-64048?
Priority 24/100. No elevated risk signals yet.